These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 7528773)
1. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. Leonard JP; Waldburger KE; Goldman SJ J Exp Med; 1995 Jan; 181(1):381-6. PubMed ID: 7528773 [TBL] [Abstract][Full Text] [Related]
2. Regulation of experimental autoimmune encephalomyelitis by interleukin-12. Leonard JP; Waldburger KE; Goldman SJ Ann N Y Acad Sci; 1996 Oct; 795():216-26. PubMed ID: 8958933 [TBL] [Abstract][Full Text] [Related]
3. Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12. Preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms. Waldburger KE; Hastings RC; Schaub RG; Goldman SJ; Leonard JP Am J Pathol; 1996 Feb; 148(2):375-82. PubMed ID: 8579100 [TBL] [Abstract][Full Text] [Related]
4. Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis. Whitham RH; Bourdette DN; Hashim GA; Herndon RM; Ilg RC; Vandenbark AA; Offner H J Immunol; 1991 Jan; 146(1):101-7. PubMed ID: 1701788 [TBL] [Abstract][Full Text] [Related]
5. The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein. van der Veen RC; Trotter JL; Clark HB; Kapp JA J Neuroimmunol; 1989 Feb; 21(2-3):183-91. PubMed ID: 2913045 [TBL] [Abstract][Full Text] [Related]
6. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice. Peng Y; Liu CP Chin Med J (Engl); 2002 Apr; 115(4):521-4. PubMed ID: 12133288 [TBL] [Abstract][Full Text] [Related]
7. Male SJL mice do not relapse after induction of EAE with PLP 139-151. Bebo BF; Vandenbark AA; Offner H J Neurosci Res; 1996 Sep; 45(6):680-9. PubMed ID: 8892079 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide. Karpus WJ; Kennedy KJ; Smith WS; Miller SD J Neurosci Res; 1996 Aug; 45(4):410-23. PubMed ID: 8872901 [TBL] [Abstract][Full Text] [Related]
9. Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline. Bright JJ; Du C; Coon M; Sriram S; Klaus SJ J Immunol; 1998 Dec; 161(12):7015-22. PubMed ID: 9862738 [TBL] [Abstract][Full Text] [Related]
10. Location of a new encephalitogenic epitope (residues 43 to 64) in proteolipid protein that induces relapsing experimental autoimmune encephalomyelitis in PL/J and (SJL x PL)F1 mice. Whitham RH; Jones RE; Hashim GA; Hoy CM; Wang RY; Vandenbark AA; Offner H J Immunol; 1991 Dec; 147(11):3803-8. PubMed ID: 1719089 [TBL] [Abstract][Full Text] [Related]
11. Treatment of relapsing autoimmune encephalomyelitis with T cell receptor V beta-specific antibodies when proteolipid protein is the autoantigen. Whitham RH; Wingett D; Wineman J; Mass M; Wegmann K; Vandenbark A; Offner H J Neurosci Res; 1996 Jul; 45(2):104-16. PubMed ID: 8843028 [TBL] [Abstract][Full Text] [Related]
12. Differential recognition of peptide analogs by naive verses activated PLP 139-151-specific CD4+ T cells. McRae BL; Nikcevich KM; Karpus WJ; Hurst SD; Miller SD J Neuroimmunol; 1995 Jul; 60(1-2):17-28. PubMed ID: 7543908 [TBL] [Abstract][Full Text] [Related]
13. Encephalitogenicity of complete Freund's adjuvant relative to CpG is linked to induction of Th17 cells. Tigno-Aranjuez JT; Jaini R; Tuohy VK; Lehmann PV; Tary-Lehmann M J Immunol; 2009 Nov; 183(9):5654-61. PubMed ID: 19812193 [TBL] [Abstract][Full Text] [Related]
14. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658 [TBL] [Abstract][Full Text] [Related]
15. Induction of experimental allergic encephalomyelitis by myelin proteolipid-protein-specific T cell clones and synthetic peptides. Kuchroo VK; Sobel RA; Yamamura T; Greenfield E; Dorf ME; Lees MB Pathobiology; 1991; 59(5):305-12. PubMed ID: 1716908 [TBL] [Abstract][Full Text] [Related]
16. A gene therapy approach for treating T-cell-mediated autoimmune diseases. Chen C; Rivera A; Ron N; Dougherty JP; Ron Y Blood; 2001 Feb; 97(4):886-94. PubMed ID: 11159513 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis. Yang C; He D; Yin C; Tan J Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284 [TBL] [Abstract][Full Text] [Related]
18. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. Renno T; Krakowski M; Piccirillo C; Lin JY; Owens T J Immunol; 1995 Jan; 154(2):944-53. PubMed ID: 7814894 [TBL] [Abstract][Full Text] [Related]
19. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. Yu M; Johnson JM; Tuohy VK J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907 [TBL] [Abstract][Full Text] [Related]
20. Experimental allergic encephalomyelitis mediated by cloned T cells specific for a synthetic peptide of myelin proteolipid protein. Fine specificity and T cell receptor V beta usage. Kuchroo VK; Sobel RA; Laning JC; Martin CA; Greenfield E; Dorf ME; Lees MB J Immunol; 1992 Jun; 148(12):3776-82. PubMed ID: 1376341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]